Customer Interview
Polygenic Risk Scores Could Become Useful Tools in the Physician's...
Researchers perform large GWAS studies with the Global Screening Array to identify disease-associated DNA risk loci and develop PRSs for clinical...
Read Article
Customer Interview
NGS Identifies Rare Disease Variants in Infants with Undiagnosed...
Landmark NGS study leads to a national clinical diagnostic exome sequencing platform in Singapore.
Read Article
Customer Videos
The Clinical Value of NIPT
Learn how noninvasive prenatal testing (NIPT) is making an impact around the world. Hear from the staff at AMES discuss how NIPT, particularly...
View VideoSimplify Rare Variant Analysis and Interpretation
Call, prioritize, and report on variants from one interface
Learn MoreTraining and Webinars
Illumina offers webinars and free online training courses to get the most out of your experiments and products
View WebinarsView CoursesFeatured Tool
Sequencing Method Explorer
Explore experimental sequencing library preparation methods compiled from the scientific literature
Find a MethodPopular Tools
MyIllumina Customer Dashboard
Sign In or Learn MoreLibrary Prep and Array Kit Selector
Launch ToolBaseSpace Sequence Hub
Sign In or Learn MoreCustom Protocol Selector
Build ProtocolDesignStudio Custom Assay Designer
Sign In or Learn More
See More Tools
Featured News
Illumina Perspective on the Novel Coronavirus SARS-CoV-2 (2019-nCoV) Outbreak:
What We Know Today and Where Do We Go from Here
Read Article| Date | Publication | Title |
|---|---|---|
| Jan 13, 2020 | CNBC | ILMN CEO at J.P. Morgan Healthcare Conference |
| Jan 3, 2020 | The Wall Street Journal | Illumina, Pacific Biosciences of California End Plans to Combine |
| Dec 3, 2019 | Yahoo! Finance | ArcherDX Announces Partnership with Illumina to Develop In-Vitro Diagnostic Tests |